Uxia Recalde-Nogueira
A Coruna, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The autophagy-recessive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) contributes to the pathogenesis of osteoarthritis.
Journal: Autophagy
Published: October 15, 2025
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation.
Journal: Signal transduction and targeted therapy
Published: September 09, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis.
Journal: Cell death and differentiation
Published: October 30, 2024
Correction: Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance.
Journal: Molecular cancer
Published: October 17, 2024
Acyl-CoA binding protein for the experimental treatment of anorexia.
Journal: Science translational medicine
Published: August 14, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver disease.
Journal: Cell death and differentiation
Published: July 02, 2024
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: March 13, 2024
A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2024
Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2024
A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2024
Last Updated: 09/26/2026